Carmen Patricia
Pérez Matute
PROFESORA TITULAR DE UNIVERSIDAD
Laura Ochoa Callejero-rekin lankidetzan egindako argitalpenak (2)
2021
2014
-
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1903-1910